The activity of platinum drugs seems not to be limited only to the triple negative BRCA1 and BRCA2 mutated tumors, but also to the sporadic TN tumors that harbor DDR deficiency. This evidence concerns the gene BRCA2 and hyperinsulinemic hypoglycemia, familial, 4.